628316-75-6

Upstream product

• 5451-40-1 2,6 dichloropurine 
• 197644-83-0 1,2-di-O-acetyl-3-O-(3',4'-di-O-acetyl-2',6'-di-O-benzyl-α-D-glucopyranosyl)-5-O-benzyl-α/β-D-ribofuranoside 

Downstream Products

• 628316-89-2 2',3'',4''-tri-O-acetyl-2'',5',6''-tri-O-benzyl-3'O-α-D-glucopyranosyl-2-chloro-6-methylamino-9-β-D-ribofuranosylpurine 
• 628316-90-5 2'',5',6''-tri-O-benzyl-3'O-α-D-glucopyranosyl-2-chloro-6-methylamino-9-β-D-ribofuranosylpurine 
• 628316-91-6 2'',5',6''-tri-O-benzyl-3'O-α-D-glucopyranosyl-2-methoxy-6-methylamino-9-β-D-ribofuranosylpurine 

Relevant academic research and scientific papers

Synthesis and Ca2+-mobilizing activity of purine-modified mimics of adenophostin A: a model for the adenophostin-Ins(1,4,5)P3 receptor interaction.

The synthesis of a series of adenophostin A analogues modified at C-6 and C-2 of adenine is described. The target compounds were synthesized by a convergent route involving a modified Vorbrueggen condensation of either 6-chloropurine or 2,6-dichloropurine